Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients

• Published in: Gynecologic oncology Vol. 146; no. 2; pp. 380 - 385
• Main Authors: Eggink, F.A., Mom, C.H., Boll, D., Ezendam, N.P.M., Kruitwagen, R.F.P.M., Pijnenborg, J.M.A., van der Aa, M.A., Nijman, H.W.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2017
• Subjects: Adenocarcinoma, Clear Cell - pathology; Adenocarcinoma, Clear Cell - therapy; Adjuvant therapy; Adult; Aged; Aged, 80 and over; Carcinoma, Endometrioid - pathology; Carcinoma, Endometrioid - therapy; Chemotherapy, Adjuvant - utilization; Compliance; Endometrial cancer; Endometrial Neoplasms - pathology; Endometrial Neoplasms - therapy; Female; Guideline Adherence - statistics & numerical data; Guidelines; Hematology, Oncology and Palliative Medicine; High risk; Humans; Hysterectomy; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous - pathology; Neoplasms, Cystic, Mucinous, and Serous - therapy; Netherlands; Obstetrics and Gynecology; Overall survival; Practice Guidelines as Topic; Quality Improvement; Radiotherapy, Adjuvant - utilization; Registries; Risk; High risk; Endometrial cancer; Compliance; Overall survival; Adjuvant therapy; Guidelines

Compliance of physicians with guidelines has emerged as an important indicator for quality of care. We evaluated compliance of physicians with adjuvant therapy guidelines for endometrial cancer patients in the Netherlands in a population-based cohort over a period of 10years. Data from all patients...